LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-5.75 Cr | ₹-8.32 Cr | ₹-8.14 Cr | ₹4.52 Cr | ₹-3.57 Cr |
What is the latest Cash Flow from Financing Activities ratio of LACTOSE (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-5.75 Cr |
Mar2023 | ₹-8.32 Cr |
Mar2022 | ₹-8.14 Cr |
Mar2021 | ₹4.52 Cr |
Mar2020 | ₹-3.57 Cr |
How is Cash Flow from Financing Activities of LACTOSE (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.75 Cr | Negative | |
Mar2023 | ₹-8.32 Cr | Negative | |
Mar2022 | ₹-8.14 Cr | Negative | |
Mar2021 | ₹4.52 Cr | Positive | |
Mar2020 | ₹-3.57 Cr | - |
Compare Cash Flow from Financing Activities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹258.8 Cr | -2.9% | -12.5% | 68.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,143.0 Cr | -1.2% | 0.9% | 41.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,578.0 Cr | -3.7% | -1.8% | 46.1% | Stock Analytics | |
CIPLA | ₹120,185.0 Cr | -1.5% | 2.2% | 16.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,450.0 Cr | 1.4% | 10.6% | 17.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,569.0 Cr | 3.5% | 3.6% | 37.4% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -2.9% |
-12.5% |
68.8% |
SENSEX | -2.9% |
-4.8% |
8% |
You may also like the below Video Courses